Left ventricular hypertrophy in hypertension: Its arrhythmogenic potential

被引：134

作者：

Kahan, T

Bergfeldt, L ^{[1
]}

机构：

[1] Univ Gothenburg, Sahlgrens Univ Hosp S, Sahlgrenska Acad, S-41345 Gothenburg, Sweden

[2] Karolinska Inst, Danderyd Hosp, Div Internal Med, Stockholm, Sweden

来源：

HEART | 2005年 / 91卷 / 02期

关键词：

D O I：

10.1136/hrt.2004.042473

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：250 / 256

页数：7

共 20 条

[1]

Aronson RS., 1991, J CARDIOVASC ELECTR, V2, P249, DOI [10.1111/j.1540-8167.1991.tb01323.x, DOI 10.1111/J.1540-8167.1991.TB01323.X]

[2] Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease [J].

Brilla, CG ;

Funck, RC ;

Rupp, H .

CIRCULATION, 2000, 102 (12) :1388-1393

[3] Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril [J].

González-Juanatey, JR ;

Garcia-Acuña, JM ;

Pose, A ;

Varela, A ;

Calvo, C ;

Cabezas-Cerrato, J ;

de la Peña, MG .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (02) :170-174

[4] CELLULAR ELECTROPHYSIOLOGY IN CARDIAC-HYPERTROPHY AND FAILURE [J].

HART, G .

CARDIOVASCULAR RESEARCH, 1994, 28 (07) :933-946

[5]

Kahan T, 1998, J HYPERTENS, V16, pS23

[6] Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension [J].

Karpanou, EA ;

Vyssoulis, GP ;

Psichogios, A ;

Malakou, C ;

Kyrozi, EA ;

Cokkinos, DV ;

Toutouzas, PK .

AMERICAN HEART JOURNAL, 1998, 136 (05) :765-768

[7] A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension [J].

Klingbeil, AU ;

Schneider, M ;

Martus, P ;

Messerli, FH ;

Schmieder, RE .

AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01) :41-46

[8] RELATION OF LEFT-VENTRICULAR MASS AND GEOMETRY TO MORBIDITY AND MORTALITY IN UNCOMPLICATED ESSENTIAL-HYPERTENSION [J].

KOREN, MJ ;

DEVEREUX, RB ;

CASALE, PN ;

SAVAGE, DD ;

LARAGH, JH .

ANNALS OF INTERNAL MEDICINE, 1991, 114 (05) :345-352

[9] Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during anti hypertensive treatment:: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial [J].

Kurland, L ;

Melhus, H ;

Karlsson, J ;

Kahan, T ;

Malmqvist, K ;

Öhman, P ;

Nyström, F ;

Hägg, A ;

Lind, L .

JOURNAL OF HYPERTENSION, 2002, 20 (04) :657-663

[10] Irbesartan reduces QT dispersion in hypertensive individuals [J].

Lim, PO ;

Nys, M ;

Naas, AAO ;

Struthers, AD ;

Osbakken, M ;

MacDonald, TM .

HYPERTENSION, 1999, 33 (02) :713-718

← 1 2 →